↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$225KSold on the market
1Companies
Oct 19, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202613:48 | Oct 15, 2026 | RAREUltragenyx Pharmaceutical Inc. | Chief Financial Officer | S · Sell | $15.27 | −7,066 | 89,229 | -7% | −$108K | ||
| Aug 4, 202615:13 | Aug 3, 2026 | RAREUltragenyx Pharmaceutical Inc. | Chief Financial Officer | S · Sell10b5-1 | $24.92 | −4,696 | 96,295 | -5% | −$117K |